Authors :
Siddharath Kansal
Volume/Issue :
Volume 7 - 2022, Issue 2 - February
Google Scholar :
http://bitly.ws/gu88
Scribd :
https://bit.ly/3IOXNBS
DOI :
https://doi.org/10.5281/zenodo.6334732
Abstract :
The corona virus pandemic is an ongoing
pandemic which originated from Wuhan, China in
December 2019. It was declared a pandemic on 11 March
2020 by the World health organization and has affected
almost every Industry around the world. This review paper
will talk about the positive and negative effects the Covid19 pandemic has had on the Indian pharmaceutical industry
and briefly look at the challenges that the industry needs to
overcome. From December 2019 to December 2021, the
Indian pharmaceutical industry has seen an increased in
demand, exports, investment, collaboration, and growth
which can be attributed towards dealing with the pandemic.
The increased global healthcare demands have stimulated
growth in the industry. However, there have been
challenges the industry had to face including the disruptions
in supply chain networks, an increase in raw material costs,
and slowing down of research and development for new
non-covid related drugs. The pandemic has presented the
Indian pharmaceutical industry with an opportunity to
become ‘the pharmacy of the world’ for which it must
overcome the shortcomings that have been exposed during
the pandemic. India is the leading manufacturer and
exporter of generic medicines in the world but is heavily
dependent on countries like China for raw materials and
key starting ingredients. Improvements in policy and supply
chain networks are required for India to keep up with the
growing healthcare needs of the Indian population.
Keywords :
Corona Virus; Pandemic; India; Pharmacutical Industry.
The corona virus pandemic is an ongoing
pandemic which originated from Wuhan, China in
December 2019. It was declared a pandemic on 11 March
2020 by the World health organization and has affected
almost every Industry around the world. This review paper
will talk about the positive and negative effects the Covid19 pandemic has had on the Indian pharmaceutical industry
and briefly look at the challenges that the industry needs to
overcome. From December 2019 to December 2021, the
Indian pharmaceutical industry has seen an increased in
demand, exports, investment, collaboration, and growth
which can be attributed towards dealing with the pandemic.
The increased global healthcare demands have stimulated
growth in the industry. However, there have been
challenges the industry had to face including the disruptions
in supply chain networks, an increase in raw material costs,
and slowing down of research and development for new
non-covid related drugs. The pandemic has presented the
Indian pharmaceutical industry with an opportunity to
become ‘the pharmacy of the world’ for which it must
overcome the shortcomings that have been exposed during
the pandemic. India is the leading manufacturer and
exporter of generic medicines in the world but is heavily
dependent on countries like China for raw materials and
key starting ingredients. Improvements in policy and supply
chain networks are required for India to keep up with the
growing healthcare needs of the Indian population.
Keywords :
Corona Virus; Pandemic; India; Pharmacutical Industry.
